University of Miami
University of Miami was paid $7.50M by Medicaid between Jan 2018 and Dec 2024, across 344 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 21% of everything it billed.
MIAMI, FL 33136
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 363,776 | $370K | |
| 2019 | 745,112 | $1.50M | |
| 2020 | 701,332 | $1.95M | |
| 2021 | 621,287 | $1.39M | |
| 2022 | 383,595 | $887K | |
| 2023 | 237,897 | $1.01M | |
| 2024incomplete | 98,792 | $392K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 21% | 35,334 | 27,875 | $1.55M |
| 80053 | Comprehensive metabolic panel | 13% | 255,781 | 112,584 | $974K |
| 88307 | 7.2% | 10,531 | 9,403 | $540K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.2% | 135,207 | 46,799 | $386K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.0% | 21,435 | 19,144 | $378K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.6% | 11,568 | 9,276 | $272K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 3.0% | 13,863 | 11,794 | $226K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 354,684 | 138,129 | $211K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.2% | 2,567 | 2,214 | $165K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.0% | 17,518 | 11,750 | $147K |
| 82803 | 1.9% | 73,031 | 18,964 | $144K | |
| 87631 | 1.3% | 3,706 | 3,412 | $101K |
332 more codes
| 83735 | 1.3% | 203,874 | $99K | |
| 85027 | <1% | 86,892 | $69K | |
| 87040 | <1% | 59,862 | $68K | |
| 87799 | <1% | 6,225 | $62K | |
| 80202 | <1% | 20,339 | $58K | |
| 80197 | <1% | 21,634 | $56K | |
| 87497 | <1% | 9,267 | $49K | |
| 80069 | <1% | 22,265 | $48K | |
| 85730 | <1% | 99,524 | $47K | |
| 86480 | <1% | 1,875 | $47K | |
| 86235 | <1% | 5,921 | $41K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 2,837 | $39K |
| 88173 | <1% | 1,181 | $37K | |
| 87077 | <1% | 27,025 | $36K | |
| 82784 | <1% | 9,077 | $36K | |
| 84484 | <1% | 43,121 | $35K | |
| 88342 | <1% | 4,640 | $35K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 833 | $35K |
| 84100 | <1% | 133,822 | $35K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 7,702 | $32K |
| 82607 | <1% | 9,949 | $32K | |
| 82330 | <1% | 46,070 | $31K | |
| 88189 | <1% | 746 | $31K | |
| 88112 | <1% | 5,795 | $30K | |
| 82746 | <1% | 8,595 | $29K | |
| 82728 | <1% | 23,790 | $28K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 24,844 | $28K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,026 | $28K |
| 87070 | <1% | 26,699 | $27K | |
| 85610 | <1% | 100,762 | $26K | |
| 88304 | <1% | 3,727 | $26K | |
| 86360 | <1% | 3,828 | $25K | |
| 83605 | <1% | 33,733 | $23K | |
| 83970 | <1% | 4,685 | $23K | |
| 81001 | <1% | 68,833 | $23K | |
| 86803 | <1% | 14,759 | $23K | |
| 84146 | <1% | 14,430 | $23K | |
| 87536 | <1% | 2,547 | $23K | |
| 80061 | Lipid panel | <1% | 19,918 | $22K |
| 82553 | <1% | 7,497 | $22K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 10,492 | $22K |
| 84702 | <1% | 15,755 | $21K | |
| 86832 | <1% | 1,857 | $21K | |
| 88108 | <1% | 3,534 | $21K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 32,028 | $21K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 10,211 | $20K |
| 87340 | <1% | 15,276 | $20K | |
| 82247 | <1% | 29,742 | $18K | |
| 88341 | <1% | 641 | $18K | |
| 83883 | <1% | 3,523 | $18K | |
| 82378 | <1% | 5,494 | $18K | |
| 85046 | <1% | 7,403 | $17K | |
| 80051 | <1% | 15,483 | $16K | |
| 87305 | <1% | 975 | $15K | |
| 88311 | <1% | 4,102 | $15K | |
| 83615 | <1% | 40,564 | $15K | |
| 85384 | <1% | 18,439 | $14K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 21,352 | $14K |
| 87449 | <1% | 3,210 | $13K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 243 | $13K |
| 85007 | <1% | 22,372 | $13K | |
| 82248 | <1% | 33,772 | $12K | |
| 82375 | <1% | 10,971 | $12K | |
| 84439 | <1% | 9,531 | $12K | |
| 80076 | <1% | 8,358 | $12K | |
| 86301 | <1% | 2,108 | $11K | |
| 86140 | <1% | 32,206 | $11K | |
| 82550 | <1% | 21,934 | $11K | |
| 83880 | <1% | 15,719 | $10K | |
| 86762 | <1% | 8,010 | $10K | |
| 87640 | <1% | 1,592 | $9K | |
| 87150 | <1% | 5,612 | $9K | |
| 86787 | <1% | 7,389 | $9K | |
| 84165 | <1% | 7,033 | $9K | |
| 81003 | <1% | 22,640 | $9K | |
| 83690 | <1% | 26,218 | $8K | |
| 82947 | <1% | 27,291 | $8K | |
| 86769 | <1% | 907 | $8K | |
| 88377 | <1% | 218 | $7K | |
| 85379 | <1% | 11,538 | $7K | |
| 86922 | <1% | 285 | $7K | |
| 86304 | <1% | 1,408 | $7K | |
| 84112 | <1% | 1,051 | $7K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 698 | $7K |
| 86777 | <1% | 5,584 | $7K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 4,984 | $6K |
| 86920 | <1% | 6,438 | $6K | |
| 81025 | <1% | 4,046 | $6K | |
| 80323 | <1% | 138 | $6K | |
| 84134 | <1% | 5,834 | $6K | |
| 84155 | <1% | 8,098 | $6K | |
| 82140 | <1% | 6,097 | $6K | |
| 84681 | <1% | 1,335 | $6K | |
| 88302 | <1% | 1,183 | $6K | |
| 87581 | <1% | 2,055 | $6K | |
| 87486 | <1% | 2,043 | $6K | |
| 86300 | <1% | 1,282 | $6K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 15,241 | $6K |
| 82977 | <1% | 13,137 | $5K | |
| 84550 | <1% | 23,122 | $5K | |
| 86317 | <1% | 4,702 | $5K | |
| 82533 | <1% | 2,122 | $5K | |
| 87186 | <1% | 21,454 | $5K | |
| 86880 | <1% | 9,652 | $5K | |
| 83520 | <1% | 1,494 | $5K | |
| 80195 | <1% | 1,635 | $5K | |
| 82785 | <1% | 676 | $5K | |
| 85130 | <1% | 970 | $5K | |
| 83550 | <1% | 9,583 | $5K | |
| 83540 | <1% | 11,369 | $5K | |
| 87300 | <1% | 1,118 | $5K | |
| 86850 | <1% | 16,141 | $4K | |
| 82150 | <1% | 8,429 | $4K | |
| 87641 | <1% | 1,864 | $4K | |
| 82435 | <1% | 14,681 | $4K | |
| 82570 | <1% | 11,035 | $4K | |
| 87205 | <1% | 23,493 | $4K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 887 | $4K |
| 80050 | General health panel | <1% | 334 | $4K |
| 86334 | <1% | 4,877 | $3K | |
| 86147 | <1% | 2,153 | $3K | |
| 84132 | <1% | 13,646 | $3K | |
| 84295 | <1% | 13,409 | $3K | |
| 86709 | <1% | 1,247 | $3K | |
| 84153 | <1% | 2,036 | $3K | |
| 87507 | <1% | 480 | $3K | |
| 82610 | <1% | 1,552 | $3K | |
| 87529 | <1% | 620 | $3K | |
| 86901 | <1% | 10,513 | $3K | |
| 80164 | <1% | 2,200 | $3K | |
| 85055 | <1% | 6,361 | $3K | |
| 88360 | <1% | 97 | $3K | |
| 87075 | <1% | 6,505 | $3K | |
| 83050 | <1% | 11,212 | $3K | |
| 87899 | <1% | 2,508 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 274 | $3K |
| 82105 | <1% | 2,046 | $2K | |
| 84480 | <1% | 2,409 | $2K | |
| 85390 | <1% | 627 | $2K | |
| 80299 | <1% | 1,233 | $2K | |
| 87209 | <1% | 784 | $2K | |
| 87653 | <1% | 1,308 | $2K | |
| 87210 | <1% | 5,833 | $2K | |
| 83010 | <1% | 2,580 | $2K | |
| 87116 | <1% | 4,018 | $2K | |
| 85660 | <1% | 4,677 | $2K | |
| 84703 | <1% | 3,733 | $2K | |
| 86704 | <1% | 2,261 | $2K | |
| 86038 | <1% | 1,756 | $2K | |
| 85045 | <1% | 5,584 | $2K | |
| 83020 | <1% | 845 | $2K | |
| 87556 | <1% | 315 | $2K | |
| 80074 | <1% | 430 | $2K | |
| 83935 | <1% | 2,624 | $2K | |
| 85652 | <1% | 9,237 | $2K | |
| 87102 | <1% | 4,440 | $2K | |
| 86708 | <1% | 1,147 | $2K | |
| 89051 | <1% | 3,769 | $2K | |
| 85378 | <1% | 1,294 | $1K | |
| 86705 | <1% | 1,561 | $1K | |
| 85060 | <1% | 183 | $1K | |
| 86592 | <1% | 8,160 | $1K | |
| 86703 | <1% | 3,423 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 96 | $1K |
| 86039 | <1% | 1,406 | $1K | |
| 87496 | <1% | 443 | $1K | |
| 86146 | <1% | 192 | $1K | |
| 86778 | <1% | 796 | $1K | |
| 85097 | <1% | 96 | $1K | |
| 83930 | <1% | 3,375 | $1K | |
| 87252 | <1% | 1,255 | $1K | |
| 84478 | <1% | 2,015 | $1K | |
| 86359 | <1% | 3,936 | $1K | |
| 87081 | <1% | 1,986 | $1K | |
| 86696 | <1% | 343 | $1K | |
| 86160 | <1% | 1,004 | $975.94 | |
| 86663 | <1% | 294 | $971.66 | |
| 87106 | <1% | 434 | $968.22 | |
| 88291 | <1% | 168 | $965.93 | |
| 84300 | <1% | 2,946 | $962.44 | |
| 86833 | <1% | 1,851 | $934.75 | |
| 87206 | <1% | 3,390 | $920.63 | |
| 86355 | <1% | 3,860 | $913.62 | |
| 86828 | <1% | 1,092 | $892.74 | |
| 87015 | <1% | 2,373 | $865.29 | |
| 86022 | <1% | 270 | $864.96 | |
| 82950 | <1% | 3,021 | $858.92 | |
| 88141 | <1% | 395 | $838.52 | |
| 84481 | <1% | 656 | $836.13 | |
| 85597 | <1% | 161 | $824.46 | |
| 85014 | <1% | 2,382 | $817.12 | |
| 86357 | <1% | 3,874 | $796.47 | |
| 86645 | <1% | 453 | $776.94 | |
| 85347 | <1% | 2,773 | $760.76 | |
| 84436 | <1% | 1,306 | $734.90 | |
| 83051 | <1% | 629 | $714.72 | |
| 86644 | <1% | 929 | $706.35 | |
| G0452 | Molecular pathology procedure; physician interpretation and report | <1% | 336 | $694.63 |
| 86694 | <1% | 633 | $687.77 | |
| 86255 | <1% | 201 | $652.50 | |
| 86077 | <1% | 86 | $648.42 | |
| 82043 | <1% | 4,172 | $632.32 | |
| 86665 | <1% | 772 | $605.97 | |
| 86701 | <1% | 825 | $601.04 | |
| 87149 | <1% | 112 | $567.35 | |
| 84466 | <1% | 735 | $553.40 | |
| 82945 | <1% | 2,615 | $548.34 | |
| 86902 | <1% | 702 | $546.78 | |
| 87522 | Neg quan hep c or qual rna | <1% | 93 | $536.58 |
| 80320 | <1% | 718 | $530.71 | |
| 85247 | <1% | 70 | $516.16 | |
| 85049 | <1% | 1,034 | $516.04 | |
| 88300 | <1% | 272 | $510.10 | |
| 82436 | <1% | 2,436 | $494.45 | |
| 81401 | <1% | 2,391 | $461.18 | |
| 84540 | <1% | 1,728 | $435.37 | |
| 85018 | <1% | 2,359 | $428.02 | |
| 85651 | <1% | 1,694 | $410.97 | |
| 82270 | <1% | 584 | $401.52 | |
| 84157 | <1% | 1,658 | $396.39 | |
| 87532 | <1% | 270 | $393.12 | |
| 86706 | <1% | 465 | $372.91 | |
| 87324 | <1% | 1,498 | $365.09 | |
| 87498 | <1% | 321 | $344.00 | |
| 80185 | <1% | 288 | $342.73 | |
| 84156 | <1% | 1,157 | $312.88 | |
| 88313 | <1% | 180 | $309.58 | |
| 88312 | <1% | 40 | $308.40 | |
| 87181 | <1% | 819 | $307.25 | |
| 0352U | <1% | 53 | $305.87 | |
| 87481 | <1% | 31 | $299.68 | |
| 85240 | <1% | 96 | $275.81 | |
| 82009 | <1% | 833 | $270.03 | |
| 85576 | <1% | 60 | $265.01 | |
| 80360 | <1% | 139 | $263.72 | |
| 87493 | <1% | 884 | $256.49 | |
| 85670 | <1% | 653 | $249.83 | |
| 86431 | <1% | 276 | $249.41 | |
| 82960 | <1% | 587 | $237.61 | |
| 80356 | <1% | 138 | $234.42 | |
| 82310 | <1% | 529 | $233.45 | |
| 80357 | <1% | 136 | $219.45 | |
| 86900 | <1% | 9,102 | $211.81 | |
| 80162 | <1% | 183 | $207.13 | |
| 87430 | <1% | 342 | $206.71 | |
| 86870 | <1% | 182 | $205.86 | |
| 87045 | <1% | 582 | $193.72 | |
| 86695 | <1% | 351 | $192.03 | |
| 80344 | <1% | 136 | $186.05 | |
| 86702 | <1% | 49 | $184.49 | |
| 83992 | <1% | 146 | $179.76 | |
| 82010 | <1% | 604 | $175.85 | |
| 83521 | <1% | 175 | $168.49 | |
| 80364 | <1% | 137 | $164.75 | |
| 82805 | <1% | 52 | $158.60 | |
| 86664 | <1% | 287 | $155.56 | |
| 80340 | <1% | 135 | $150.02 | |
| 83516 | <1% | 139 | $145.19 | |
| 80349 | <1% | 136 | $143.36 | |
| 80365 | <1% | 139 | $143.20 | |
| 80338 | <1% | 137 | $142.99 | |
| 80366 | <1% | 134 | $142.50 | |
| 80373 | <1% | 137 | $141.75 | |
| 80348 | <1% | 138 | $140.49 | |
| 86780 | <1% | 377 | $131.30 | |
| 80337 | <1% | 137 | $128.49 | |
| 80346 | <1% | 138 | $128.00 | |
| 80198 | <1% | 148 | $123.97 | |
| 87071 | <1% | 1,364 | $122.57 | |
| 80368 | <1% | 136 | $121.96 | |
| 80326 | <1% | 136 | $121.72 | |
| 80354 | <1% | 138 | $116.25 | |
| 87177 | <1% | 513 | $114.17 | |
| 80359 | <1% | 136 | $113.39 | |
| 87176 | <1% | 520 | $111.88 | |
| 84479 | <1% | 32 | $110.52 | |
| 80333 | <1% | 137 | $109.76 | |
| 85300 | <1% | 64 | $100.35 | |
| 82103 | <1% | 71 | $97.86 | |
| 80370 | <1% | 138 | $94.76 | |
| 80345 | <1% | 138 | $94.53 | |
| 80358 | <1% | 136 | $92.00 | |
| 80367 | <1% | 138 | $92.00 | |
| 80372 | <1% | 136 | $92.00 | |
| 80361 | <1% | 138 | $92.00 | |
| 86682 | <1% | 358 | $89.06 | |
| 82040 | <1% | 374 | $83.20 | |
| 82787 | <1% | 53 | $80.10 | |
| 85520 | <1% | 60 | $78.71 | |
| 85460 | <1% | 26 | $74.89 | |
| 82390 | <1% | 159 | $72.25 | |
| 89050 | <1% | 119 | $70.62 | |
| 85732 | <1% | 35 | $69.63 | |
| 85302 | <1% | 69 | $69.36 | |
| 80330 | <1% | 138 | $69.00 | |
| 86687 | <1% | 194 | $68.49 | |
| 82042 | <1% | 623 | $68.09 | |
| 86593 | <1% | 137 | $67.40 | |
| 83002 | <1% | 34 | $59.26 | |
| 83001 | <1% | 60 | $58.19 | |
| 83721 | <1% | 42 | $57.83 | |
| 80355 | <1% | 113 | $54.90 | |
| 81015 | <1% | 265 | $54.42 | |
| 82951 | <1% | 121 | $50.03 | |
| 84133 | <1% | 123 | $48.80 | |
| 82274 | <1% | 102 | $40.11 | |
| 84520 | <1% | 47 | $37.79 | |
| 80170 | <1% | 16 | $33.12 | |
| 83655 | <1% | 12 | $22.95 | |
| 82232 | <1% | 14 | $21.43 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 45 | $18.52 |
| 82952 | <1% | 76 | $17.76 | |
| 87338 | <1% | 15 | $17.17 | |
| 84450 | <1% | 49 | $13.84 | |
| 82725 | <1% | 13 | $13.31 | |
| 84460 | <1% | 39 | $12.11 | |
| 84591 | <1% | 43 | $12.08 | |
| 87807 | <1% | 16 | $11.39 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 614 | $10.80 |
| 80329 | <1% | 34 | $9.00 | |
| 80321 | <1% | 137 | $9.00 | |
| 85613 | <1% | 16 | $7.20 | |
| 82465 | <1% | 18 | $6.92 | |
| 80353 | <1% | 136 | $3.50 | |
| 83090 | <1% | 14 | $3.27 | |
| 82565 | <1% | 14 | $3.23 | |
| 87046 | <1% | 15 | $2.12 | |
| 86945 | 0% | 60 | $0.00 | |
| 87184 | 0% | 13 | $0.00 | |
| 87281 | 0% | 17 | $0.00 | |
| 86790 | 0% | 23 | $0.00 | |
| 80377 | 0% | 135 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| University of Miami | Miami, FL | $5.37M |
| University of Miami | Miami, FL | $4.30M |
| University of Miami | Miami, FL | $4.14M |
| University of Miami | Miami, FL | $3.28M |
| University of Miami | Miami, FL | $3.19M |
| University of Miami | Miami, FL | $2.43M |
| University of Miami | Miami, FL | $1.96M |
| University of Miami | Miami, FL | $1.82M |
| University of Miami | Miami, FL | $1.56M |
| University of Miami | Miami, FL | $1.50M |
| University of Miami | Miami, FL | $1.45M |
| University of Miami | Miami, FL | $1.39M |
| University of Miami | Miami, FL | $1.25M |
| University of Miami | Miami, FL | $1.22M |
| University of Miami | Miami, FL | $1.19M |
| University of Miami | Miami, FL | $1.15M |
| University of Miami | Miami, FL | $1.03M |
| University of Miami | Miami, FL | $972K |
| University of Miami | Miami, FL | $851K |
| University of Miami | Miami, FL | $768K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.